摘要
背景:克罗恩病(CD)是一种慢性,致残和破坏性疾病。一半患者会发生肠道损伤(狭窄,瘘管和/或脓肿)。目前的治疗策略未能改变其自然史。 目标:我们在一篇综述文章中探讨了从治疗强化的线性序列到集中于个性化患者护理的复杂算法超过四分之一个世纪的CD治疗的演变。具体而言,我们将重点放在评估疾病严重程度,选择严格的治疗目标,开始有效的治疗疗法以及管理继发性应答损失等不断发展的概念上。 结果:严格监测炎症的客观体征和治疗至靶向的方法可能是改变患者生命和疾病过程的唯一方法。我们现在试图根据患者概况,疾病表型和随后发生的独特药效动力学优化我们的治疗工具。 结论:用最新的治疗算法标准化胃肠专科医生的临床实践可能会最大限度地减少疾病相关并发症,同时有利于患者的生活质量。
关键词: 克罗恩病,治疗目标,抗肿瘤,治疗算法,药物监测,粘膜愈合。
图形摘要
Current Drug Targets
Title:Evolving Treatment Algorithms in Crohn's Disease
Volume: 19 Issue: 7
关键词: 克罗恩病,治疗目标,抗肿瘤,治疗算法,药物监测,粘膜愈合。
摘要: Background: Crohn's disease (CD) is a chronic, disabling and destructive condition. Half of patients will develop some bowel damage (stricture, fistula and/or abscess). Current therapeutic strategies failed to alter its natural history.
Objective: We explore in a review article the evolution of CD treatment over a quarter of a century from a linear sequence of treatment intensification to a complex algorithm focused on individualized patient care by looking beyond symptoms. Specifically we focus on evolving concepts in assessing disease severity, selecting rigorous treatment end-targets, initiating an effective therapeutic therapy, and managing secondary loss of response.
Results: A tight monitoring of objective signs of inflammation and a treat-to-target approach are probably the only way to change patients' life and disease course. We now seek to optimize our therapeutic tools according to patient profile, disease phenotype and the unique pharmacodynamics that ensues.
Conclusion: Standardizing the clinical practice of gastroenteroogists with the most current treatment algorithm may minimize disease related complications while favouring patient’s quality of life.
Export Options
About this article
Cite this article as:
Evolving Treatment Algorithms in Crohn's Disease, Current Drug Targets 2018; 19 (7) . https://dx.doi.org/10.2174/1389450117666160607075557
DOI https://dx.doi.org/10.2174/1389450117666160607075557 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Focal Adhesion Kinase as a Therapeutic Target of Bortezomib
Anti-Cancer Agents in Medicinal Chemistry Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
Anti-Cancer Agents in Medicinal Chemistry From Stem Cell Biology to The Treatment of Lung Diseases
Current Stem Cell Research & Therapy Anti-Proliferative Effects of Novel Glyco-Lipid-Arsenicals (III) on MCF-7 Human Breast Cancer Cells
Medicinal Chemistry Oligodeoxynucleotide Acid Loaded, NGR-Peptide-Conjugated Polymeric Liposomes: In Vitro and In Vivo Evaluation
Current Nanoscience Mitosis-Targeting Natural Products for Cancer Prevention and Therapy
Current Drug Targets Quantification of Intracellular Proteins and Monitoring Therapy Using Flow Cytometry
Current Drug Targets Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy
Current Enzyme Inhibition Immunossupressant and Organ Transplantation: Immunophilins Targeting Agent and Alternative Therapies
Current Medicinal Chemistry Targeting Transcription Factors in Acute Leukemia in Children
Current Drug Targets Discovery of New Aminosubstituted Pyrrolopyrimidines with Antiproliferative Activity Against Breast Cancer Cells and Investigation of their Effect Towards the PI3Kα Enzyme
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: The Effects of Anticancer Agents on Cell Apoptosis and on the Expression of Cancer - Related Genes)
Anti-Cancer Agents in Medicinal Chemistry Withdrawal Notice: Prognosis And Prediction Of Breast Cancer (Bc) Using Growing Mlt (Machine Learning Techniques)
Recent Advances in Computer Science and Communications The Clinical Spectrum, Diagnosis, Pathogenesis and Treatment of Hashimotos Encephalopathy (Recurrent Acute Disseminated Encephalomyelitis)
Current Medicinal Chemistry Assessment of Bishosphonate Activity In Vitro
Current Pharmaceutical Design The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis
Current Signal Transduction Therapy Study of Atomic Force Microscopy in Pharmaceutical and Biopharmaceutical Interactions - A Mini Review
Current Pharmaceutical Analysis γ-Tocotrienol Induces Apoptosis in Human T Cell Lymphoma through Activation of Both Intrinsic and Extrinsic Pathways
Current Pharmaceutical Design Protein Kinase A (PKA) - A Potential Target for Therapeutic Intervention of Dysfunctional Immune Cells
Current Drug Targets